Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedOct 12, 2024
DataAggregated Company Financials
Companies7
  • 7D2.9%
  • 3M2.8%
  • 1Y10.1%
  • YTD10.6%

Over the last 7 days, the Pharma industry has remained flat. The past year has been better, since the industry has gained 7.9% in that time. As for the next few years, earnings are expected to grow by 12% per annum.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 13 Oct 2024CHF 457.6bCHF 115.3bCHF 19.4b21.7x23.6x4x
Tue, 10 Sep 2024CHF 455.8bCHF 114.8bCHF 19.3b21.8x23.6x4x
Thu, 08 Aug 2024CHF 453.7bCHF 115.5bCHF 19.5b22.5x23.3x3.9x
Sat, 06 Jul 2024CHF 430.8bCHF 116.2bCHF 19.7b34.1x21.8x3.7x
Mon, 03 Jun 2024CHF 412.6bCHF 116.7bCHF 19.8b41.9x20.8x3.5x
Wed, 01 May 2024CHF 393.9bCHF 113.9bCHF 20.0b38.4x19.7x3.5x
Fri, 29 Mar 2024CHF 392.0bCHF 112.0bCHF 19.4b38.1x20.2x3.5x
Sun, 25 Feb 2024CHF 390.6bCHF 110.4bCHF 19.7b24.8x19.8x3.5x
Tue, 23 Jan 2024CHF 418.2bCHF 120.5bCHF 18.8b27.4x22.2x3.5x
Thu, 21 Dec 2023CHF 393.5bCHF 120.0bCHF 18.7b24.8x21x3.3x
Sat, 18 Nov 2023CHF 386.7bCHF 121.6bCHF 19.0b23.9x20.4x3.2x
Mon, 16 Oct 2023CHF 409.9bCHF 121.5bCHF 18.6b26.2x22x3.4x
Wed, 13 Sep 2023CHF 403.0bCHF 112.4bCHF 18.0b47.3x22.4x3.6x
Fri, 11 Aug 2023CHF 414.2bCHF 111.4bCHF 17.9b48.3x23.2x3.7x
Sun, 09 Jul 2023CHF 403.5bCHF 114.8bCHF 18.8b35.1x21.4x3.5x
Tue, 06 Jun 2023CHF 436.3bCHF 115.6bCHF 18.9b37.9x23x3.8x
Thu, 04 May 2023CHF 432.8bCHF 114.7bCHF 18.8b41.9x23x3.8x
Sat, 01 Apr 2023CHF 412.5bCHF 115.8bCHF 18.9b42x21.8x3.6x
Mon, 27 Feb 2023CHF 405.0bCHF 117.1bCHF 19.1b27.5x21.2x3.5x
Wed, 25 Jan 2023CHF 455.8bCHF 118.1bCHF 35.0b23.7x13x3.9x
Fri, 23 Dec 2022CHF 437.6bCHF 117.5bCHF 34.8b22.7x12.6x3.7x
Sun, 20 Nov 2022CHF 440.2bCHF 118.5bCHF 35.2b22.6x12.5x3.7x
Tue, 18 Oct 2022CHF 446.7bCHF 121.8bCHF 37.5b21x11.9x3.7x
Thu, 15 Sep 2022CHF 447.6bCHF 119.5bCHF 36.6b21.6x12.2x3.7x
Sat, 13 Aug 2022CHF 446.6bCHF 118.6bCHF 36.2b21.4x12.4x3.8x
Mon, 11 Jul 2022CHF 455.6bCHF 119.5bCHF 37.7b28.1x12.1x3.8x
Wed, 08 Jun 2022CHF 458.4bCHF 119.3bCHF 37.6b27.7x12.2x3.8x
Fri, 06 May 2022CHF 482.4bCHF 120.1bCHF 38.0b29x12.7x4x
Sun, 03 Apr 2022CHF 493.6bCHF 116.7bCHF 36.3b33.3x13.6x4.2x
Tue, 01 Mar 2022CHF 475.1bCHF 116.3bCHF 36.1b20.1x13.2x4.1x
Thu, 27 Jan 2022CHF 468.9bCHF 112.2bCHF 23.2b19.9x20.2x4.2x
Sat, 25 Dec 2021CHF 497.1bCHF 112.1bCHF 23.2b21.5x21.4x4.4x
Mon, 22 Nov 2021CHF 499.7bCHF 112.4bCHF 23.3b22.5x21.5x4.4x
Wed, 20 Oct 2021CHF 492.1bCHF 111.5bCHF 22.5b21.8x21.9x4.4x
Price to Earnings Ratio

21.9x


Total Market Cap: CHF 492.1bTotal Earnings: CHF 22.5bTotal Revenue: CHF 111.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 18.7x202220232024
Current Industry PE
  • Investors are optimistic on the Swiss Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 23.2x which is higher than its 3-year average PE of 18.7x.
  • The industry is trading close to its 3-year average PS ratio of 3.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 4.8% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market1.04%
Healthcare1.92%
Pharma2.88%
Pharma2.88%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ROG Roche HoldingCHF 268.403.8%
+CHF 7.9b		5.2%PE20.1x
NOVN NovartisCHF 99.441.8%
+CHF 3.5b		13.6%PE23.3x
SDZ Sandoz GroupCHF 37.876.8%
+CHF 1.0b		36.2%PS1.9x
GALD Galderma GroupCHF 79.511.9%
+CHF 346.8m		n/aPS5.1x
KNRS Kinarus Therapeutics HoldingCHF 16.135.9%
+CHF 213.9k		-66.7%n/a
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

COPN

CHF 74.80

Cosmo Pharmaceuticals

7D

-1.1%

1Y

99.5%

SDZ

CHF 37.87

Sandoz Group

7D

6.8%

1Y

36.2%

ROG

CHF 268.40

Roche Holding

7D

3.8%

1Y

5.2%

NOVN

CHF 99.44

Novartis

7D

1.8%

1Y

13.6%

NWRN

CHF 7.37

Newron Pharmaceuticals

7D

-3.8%

1Y

37.5%

GALD

CHF 79.51

Galderma Group

7D

1.9%

1Y

n/a

DESN

CHF 251.50

Dottikon ES Holding

7D

-1.2%

1Y

18.4%

Dottikon ES Holding AG (VTX:DESN) Not Flying Under The Radar

Jul 17
Dottikon ES Holding AG (VTX:DESN) Not Flying Under The Radar

CURN

CHF 8.24

Curatis Holding

7D

-12.0%

1Y

n/a

KNRS

CHF 16.13

Kinarus Therapeutics Holding

7D

5.9%

1Y

-66.7%